BWX Technologies, Inc. — FY 2022 Form 10-K Summary
Business context and reporting period
BWXT is a specialty manufacturer and nuclear technology company serving the U.S. Government, commercial nuclear power customers, and the medical radioisotope market. Its two reportable segments are Government Operations and Commercial Operations. The filing covers the fiscal year ended December 31, 2022, with comparisons to 2021 and 2020. The company changed its segment presentation in 2022, with prior periods recast for comparability.
Key financial metrics
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Revenue | $2.233 billion | $2.124 billion | +5.1% |
| Operating income | $348.6 million | $345.8 million | +0.8% |
| Operating margin | 15.6% | 16.3% | Down approximately 70 bps |
| Net income attributable to BWXT | $238.2 million | $305.9 million | -22.1% |
| Basic and diluted EPS | $2.60 | $3.24 | -19.8% |
| Net cash from operating activities | $244.7 million | $386.0 million | -$141.3 million |
| Capital expenditures | $198.3 million | $311.1 million | -$112.7 million |
| Backlog at year-end | $4.144 billion | $5.176 billion | -19.9% |
Net margin was approximately 10.7% in 2022 versus 14.4% in 2021. The decline in net income primarily reflected a significant deterioration in pension and postretirement mark-to-market results and other income, rather than a comparable decline in operating income.
- Government Operations: Revenue was $1.808 billion, up 4.8%; operating income was $336.5 million, up 2.1%; operating margin was 18.6% versus 19.1%.
- Commercial Operations: Revenue was $427.4 million, up 5.0%; operating income was $27.4 million, down 22.2%; operating margin was 6.4% versus 8.7%.
- Cash and liquidity: Cash, restricted cash and investments totaled $52.9 million. Management reported total liquidity of $532.7 million, including cash and available borrowing capacity, up from $347.7 million.
- Working capital: $403.8 million at year-end, compared with $314.1 million in 2021.
- Debt: Gross long-term debt was $1.294 billion, consisting of $800 million of senior notes and $500 million of Credit Facility borrowings, less $6.3 million of current maturities. Net debt carrying value was $1.283 billion after deferred issuance costs.
- Dividends and repurchases: The company paid $81.1 million in dividends and repurchased $20.0 million of stock during 2022. Approximately $397.6 million remained available under the repurchase authorization.
Material changes versus the prior comparable period
- Government Operations benefited from higher advanced technology revenue, increased nuclear component volume, favorable long-lead-material timing, higher uranium conversion and purification revenue, and $16.1 million of additional joint venture operating income, including the Savannah River Integrated Mission Completion contract.
- Government Operations also recorded an $11.3 million unfavorable contract adjustment related to non-nuclear components. The company is pursuing recovery of the related cost overruns.
- Commercial Operations revenue increased due to higher in-plant inspection, maintenance and modification services, fuel handling, and medical radioisotope activity. Profit declined because of lower Canadian wage subsidies and unfavorable contract adjustments.
- Other income declined by $83.2 million, from a $49.9 million gain to a $33.3 million loss. Pension and postretirement mark-to-market losses increased by approximately $86.2 million year over year.
- Net cash from operations declined primarily because of working-capital timing and the absence of a favorable prior-year customer payment timing effect.
- Capital spending declined as major expansion projects approached completion, although property, plant and equipment increased to $1.135 billion from $1.046 billion.
- On April 11, 2022, BWXT acquired Dynamic Controls Limited and Citadel Capital Corporation, including Cunico Corporation, for approximately $49.9 million. The acquired businesses supply engineered valves, manifolds and fittings and are included in Government Operations.
- On October 12, 2022, BWXT amended its credit facility, adding a $250 million term loan and retaining a $750 million revolving facility, both maturing in 2027. The term-loan proceeds refinanced prior revolving borrowings.
Guidance, outlook, risks and unusual items
The filing does not provide formal numerical revenue or earnings guidance. Management expects to recognize approximately 42% of year-end backlog revenue by the end of 2023, with the balance thereafter. Backlog included $88.7 million of unfunded U.S. Government work; approximately $200 million of unexercised options was excluded from backlog.
- U.S. Government contracts represented approximately 76% of consolidated revenue and 94% of Government Operations revenue, creating exposure to Congressional appropriations, budget delays, contract renewals, termination rights and procurement audits.
- The Waste Isolation Pilot Plant follow-on contract was awarded to a competitor in the fourth quarter of 2022, and transition was completed in February 2023. A follow-on award for the Portsmouth Gaseous Diffusion Plant contract was expected in the first half of 2023.
- Long-term contracts are generally recognized over time using cost-to-cost estimates. Changes in estimated costs, labor productivity, material prices, contract scope or schedule could materially affect future revenue and profit.
- Fixed-price and fixed-price incentive contracts expose BWXT to cost overruns, liquidated damages, supplier failures and execution risk. Inflation and higher labor and raw-material costs may not be fully recoverable.
- Environmental accruals, including asset retirement obligations, totaled $101.8 million at year-end. Environmental remediation estimates may change materially as site conditions and recovery from other parties become clearer.
- The company had $113.5 million of surety bonds and $37.5 million of letters of credit outstanding. It stated that current bonding and letter-of-credit capacity was adequate for existing requirements over the next 12 months, but availability is subject to third-party discretion and market conditions.
- Pension and other postretirement plans were sensitive to discount rates and asset returns. The filing reported underfunded defined benefit obligations of approximately $80.5 million and expected 2023 pension and postretirement contributions of $5.4 million and $1.4 million, respectively.
- The Price-Anderson Act, which provides certain nuclear liability protections, is scheduled to expire on December 31, 2025. Regulatory, nuclear safety, cybersecurity, environmental, insurance, labor and supply-chain risks remain material.
- The company recorded a $46.6 million pretax pension and postretirement adjustment in the fourth quarter of 2022. The 2022 results also included $12.6 million of pension settlement-related charges following the wind-up of a foreign salaried pension plan.
Important facts for investors to verify
- Reconcile the decline in net income and EPS with operating performance, pension mark-to-market losses, tax-rate changes and other non-operating items.
- Assess the sustainability and quality of the $4.144 billion backlog, including unfunded work, excluded options, contract termination rights and the expected 2023 conversion rate.
- Monitor the $11.3 million non-nuclear-component contract overrun and the likelihood and timing of any customer recovery.
- Evaluate exposure to U.S. Government appropriations and major contract renewals, including the impact of lost or rebid joint venture work.
- Review debt maturities, variable-rate exposure, covenant headroom and the effect of higher interest rates on the $500 million of Credit Facility borrowings.
- Track cash conversion, working-capital requirements, capital spending, pension contributions and planned shareholder returns.
- Review environmental accruals, decommissioning obligations, insurance coverage and potential liabilities associated with nuclear operations and historical asbestos matters.
- Confirm that the audited financial statements and internal controls received unqualified opinions from Deloitte & Touche LLP; the filing identified revenue recognition and estimated costs at completion as the critical audit matter.